← back to search

Zheng Wang

Jiangsu University · CN
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Hedgehog Signaling Pathway Studies, and Cancer Cells and Metastasis.
h-index
37
citations
4,097
works
179
NIH funding
primary concept
email

Recent publications

Exploring the role of ITGB6: fibrosis, cancer, and other diseases
APOPTOSIS 2023cited by 25position: middledoi
PIK3CG Regulates NLRP3/GSDMD-Mediated Pyroptosis in Septic Myocardial Injury
Inflammation 2023cited by 12position: middledoi
PM2.5 activated NLRP3 inflammasome and IL-1β release in MH-S cells by facilitating autophagy via activating Wnt5a
International Journal of Immunopathology and Pharmacology 2022cited by 18position: middledoi
Digestive tract reconstruction in pancreaticoduodenectomy in University Hospitals of China: a national questionnaire survey
Journal of Pancreatology 2022cited by 1position: middledoi
Low-grade elevation of palmitate and lipopolysaccharide synergistically induced β-cell damage via inhibition of neutral ceramidase
Molecular and Cellular Endocrinology 2021cited by 18position: middledoi
Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma
Gut 2019cited by 267position: middledoi
Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway
Cell Transplantation 2019cited by 47position: middledoi
RNA‐Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer
PROTEOMICS - CLINICAL APPLICATIONS 2019cited by 17position: middledoi
Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich–Containing Family, Pyrin Domain–Containing-3) Inflammasome in Cardiovascular Disorders
Arteriosclerosis Thrombosis and Vascular Biology 2018cited by 66position: firstdoi
The inhibition of heme oxygenase-1 enhances the chemosensitivity and suppresses the proliferation of pancreatic cancer cells through the SHH signaling pathway
International Journal of Oncology 2018cited by 31position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Yang Yang · Shijiazhuang Yiling Pharmaceutical (China)3 papers (2018–2023)Zheng Wu · Zhejiang Chinese Medical University2 papers (2018–2019)Chenxi Lu · Nantong University2 papers (2018–2023)Qingyong Ma · Second Military Medical University2 papers (2018–2019) · 2 papers (2018–2023)Zhen Wang · Nanjing University1 papers (2019–2019)Xue Wang · University of Illinois Chicago1 papers (2023–2023)Jie Li · Jinan University1 papers (2019–2019)Zhe Zhang · Fudan University1 papers (2023–2023)Kun Chen · The University of Texas Southwestern Medical Center1 papers (2019–2019)Jie Liu · Binzhou Medical University1 papers (2023–2023)Zhen Chen · Guangzhou University of Chinese Medicine1 papers (2019–2019)Juan Yang · Ministry of Education of the People's Republic of China1 papers (2019–2019)Chen Huang · University of Shanghai for Science and Technology1 papers (2019–2019)Yanbin Song · Jiangsu University1 papers (2023–2023)Yan Li · University of Miami1 papers (2019–2019)Wensheng Li · Shanghai Medical College of Fudan University1 papers (2019–2019)Junmin Chen · Beijing Tian Tan Hospital1 papers (2023–2023)Ye Lin · Wenzhou Medical University1 papers (2022–2022)Liying Liu · Shandong University1 papers (2019–2019)